Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 16 to 30 of 35 results for aortic aneurysm

  1. Pneumonia (community-acquired): antimicrobial prescribing (NG138)

    This guideline sets out an antimicrobial prescribing strategy for community-acquired pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.

    Antimicrobial prescribing guideline
    Published
    16 September 2019
    View recommendations

    Sections for NG138

  2. For people with favourable aneurysm morphology needing an EVAR as a primary procedure, evidence on the safety of using endoanchoring systems is adequate. However, evidence on efficacy is inadequate in quantity and quality. Therefore, for these people, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    Recommendation ID IPG725/02 Question For people with favourable aneurysm morphology needing an EVAR as a primary procedure, evidence on...

    Research recommendation
    Published
    1 June 2022

  3. What are the most effective and cost-effective frequencies for monitoring people with unruptured abdominal aortic aneurysms (AAA) of different diameters, and what is the optimal AAA threshold size (inner-to-inner maximum anterior-posterior diameter on ultrasound) for repair?

    cost-effective frequencies for monitoring people with unruptured abdominal aortic aneurysms (AAA) of different diameters, and what is...

    Research recommendation
    Published
    10 August 2020

  4. Antimicrobial prescribing: delafloxacin for acute bacterial skin and skin structure infections (ES32)

    Summary of the evidence on antimicrobial prescribing: delafloxacin

    Evidence summary
    Published
    5 January 2021

  5. Cardiometabolic disease prevention and treatment guidelines

    areas we're proposing to actively monitor Abdominal aortic aneurysm: diagnosis and management - To be confirmed Acute

    NICE guideline
    In development

  6. Thrombin injections for pseudoaneurysms (IPG60)

    Evidence-based recommendations on thrombin injections for pseudoaneurysms. This involves injecting thrombin into the pseudoaneurysm. The aim is to form a small clot to plug the ‘hole’ in the artery.

    Interventional procedures guidance
    Published
    27 May 2004
    View recommendations

    Sections for IPG60

  7. Pneumonia (hospital-acquired): antimicrobial prescribing (NG139)

    This guideline sets out an antimicrobial prescribing strategy for hospital-acquired pneumonia. It does not cover ventilator-associated pneumonia. It aims to optimise antibiotic use and reduce antibiotic resistance.

    Antimicrobial prescribing guideline
    Published
    16 September 2019
    View recommendations

    Sections for NG139

  8. Transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting (IPG561)

    Evidence-based recommendations on transcervical extracorporeal reverse flow neuroprotection for reducing the risk of stroke during carotid artery stenting in adults. This involves reversing blood flow away from the brain and filtering the blood to remove any debris.

    Interventional procedures guidance
    Published
    22 June 2016
    View recommendations

    Sections for IPG561

  9. Tocilizumab for treating giant cell arteritis (TA518)

    Evidence-based recommendations on tocilizumab (RoActemra) for treating giant cell arteritis in adults.

    Technology appraisal guidance
    Published
    18 April 2018
    View recommendations

    Sections for TA518

  10. Interventional procedures advisory committee members

    Interventional Procedures Advisory Committee members

  11. Research recommendations

    CG187/03 | Intra-aortic balloon counter‑pulsation: In people with acute heart failure and hypoperfusion syndrome, is the use of...

  12. Pancreatitis (NG104)

    This guideline covers managing acute and chronic pancreatitis in children, young people and adults. It aims to improve quality of life by ensuring that people have the right treatment and follow-up, and get timely information and support after diagnosis.

    NICE guideline
    Last updated
    16 December 2020
    View recommendations

    Sections for NG104

  13. What is the effectiveness and cost effectiveness of complex  endovascular aneurysm repair   (EVAR) versus open surgical repair in people for whom open surgical repair is suitable for: elective repair of an unruptured AAA  or emergency repair of a ruptured AAA?

    What is the effectiveness and cost effectiveness of complex endovascular aneurysm repair (EVAR) versus open surgical repair in people...

    Research recommendation
    Published
    10 August 2020

  14. Diagnosis of chronic pancreatitis:- In people with suspected (or under investigation for) chronic pancreatitis, whose diagnosis has not been confirmed by the use of 'first-line' tests (for example, CT scan, ultrasound scan, upper gastrointestinal [GI] endoscopy or combinations of these), what is the accuracy of magnetic resonance cholangiopancreatography (MRCP) with or without secretin and endoscopic ultrasound to identify whether chronic pancreatitis is present?

    gallstone disease, gastric cancer, pancreatic cancer and abdominal aortic aneurysm). First-line tests to exclude these other causes...

    Research recommendation
    Published
    17 December 2018

  15. Fasciotens for abdominal wall closure (MIB321)

    NICE has developed a medtech innovation briefing (MIB) on fasciotens for abdominal wall closure .

    Medtech innovation briefing
    Published
    25 April 2023